Profile of Cytokines TNFα, IL-1β, IL-6, IL-4, and IL-10 in Relation to Disease Progression in a Patient with Advanced Liver Alveolar Echinococcosis and Non-Optimal Antiparasitic Treatment: Four-Year Follow-Up
Open Access
Abstract
Alveolar echinococcosis (AE) is a zoonotic disease caused by the larval form of the tapeworm Echinococcus multilocularis, which is considered one of the most dangerous parasites for humans. E. multilocularis infections are most frequently observed in forestry workers, farmers, hunters, berry harvesters, and workers employed in animal shelters. The subject of this study was a four-year follow-up profile of cytokines, including tumor necrosis factor alpha (TNFα), interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-4 (IL-4), and interleukin-10 (IL-10), in a patient with advanced liver alveolar echinococcosis and non-optimal antiparasitic treatment. Ultrasound, computed tomography (CT) of the abdomen, X-ray, CT of the chest, and magnetic resonance imaging (MRI) of the head were performed during the observation and treatment of the AE patient. After antiparasitic treatment was initiated, decreased activity of the gamma-glutamyl transpeptidase (GGTP), decreased serum concentrations of immunoglobulin E, C-reactive protein (CRP), and the pro-inflammatory cytokines TNFα, IL-1, and IL-6 were observed, as well as slightly increased levels of the anti-inflammatory cytokines (IL-4 and IL-10). Conclusions. During a four-year follow-up in a patient with advanced hepatic alveolar echinococcosis and non-optimal antiparasitic treatment, a decrease in proinflammatory cytokines (TNFα, IL-1β, IL-6) and a slight increase in anti-inflammatory cytokines (IL-4, IL-10) were detected. A better understanding of cytokine regulation in infectious diseases may be important to the development of new therapeutic strategies aimed at antiparasitic treatment. We suggest that broad initiatives (preferably at the local community level) should be implemented to raise awareness of the threat of alveolar echinococcosis and methods for avoiding E. multilocularis infection.Keywords
Funding Information
- Gdański Uniwersytet Medyczny (01-30025)
This publication has 35 references indexed in Scilit:
- Alveolar echinococcosis in immunocompromised hostsClinical Microbiology and Infection, 2022
- Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the hostExperimental Parasitology, 2020
- Echinococcus multilocularisTrends in Parasitology, 2019
- First detection of Echinococcus multilocularis in environmental water sources in endemic areas using capsule filtration and molecular detection methodsWater Research, 2019
- Ultrasound images in hepatic alveolar echinococcosis and clinical stage of the diseaseAdvances in Medical Sciences, 2019
- Global Distribution of Alveolar and Cystic Echinococcosis2017
- Liver Transplantation for Incurable Alveolar Echinococcosis: An Analysis of Patients Hospitalized in Department of Tropical and Parasitic Diseases in GdyniaTransplantation Proceedings, 2016
- The first detection of Echinococcus multilocularis DNA in environmental fruit, vegetable, and mushroom samples using nested PCRParasitology Research, 2015
- First finding of Echinococcus multilocularis DNA in soil: Preliminary survey in Varmia-Masuria Province, northeast PolandVeterinary Parasitology, 2014
- WHO classification of alveolar echinococcosis: Principles and applicationParasitology International, 2006